Professor of Pediatric Surgery
University of Texas
Dr. Charles S. Cox, Jr., is Professor of Pediatric Surgery, and the George and Cynthia Mitchell Distinguished Chair in Neuroscience, directing the Pediatric Surgical Translational Laboratories and Pediatric Program in Regenerative Medicine at the University of Texas Medical School at Houston. He is co-director of the Texas Trauma Institute and directs the Pediatric Trauma Program at the UT Health/Children’s Memorial Hermann Hospital in the Texas Medical Center.
Dr. Cox received his undergraduate degree from the University of Texas at Austin in the Plan II Liberal Arts Honors Program. Upon graduating from the University of Texas Medical Branch, he completed his Surgery residency at the University of Texas Medical School at Houston. Further post-graduate fellowships were completed in Pediatric Surgery at the University of Michigan, a NIH T32 sponsored clinical and research fellowship at the Shriner’s Burns Institute, and Surgical Critical Care/Trauma at the UT Healthl at Houston. He is certified by the American Board of Surgery in Surgery, Pediatric Surgery and Surgical Critical Care. He served in Afghanistan with the 82nd Airborne in the 909th Forward Surgical Team in 2002.
The Pediatric Translational Laboratories (https://med.uth.edu/pediatricsurgery/research/research-centers-and-programs/translational-laboratories/) and Pediatric Program in Regenerative Medicinerepresent a multi-disciplinary effort that addresses problems that originate with traumatic injury and the consequences of resuscitation and critical care. The program has been continuously funded since 1998. The Program is housed in state-of-the-art laboratory facilities, and includes two cGMP facilities for the production of clinical grade cell and tissue products. Other major areas of interest include: (1) resuscitation induced organ edema and dysfunction, (2) the neuroinflammatory reflex, (3) mesenchymal stromal cell exosomes as anti-inflammatory agents, and (4) mechanotransduction of stem cells to enhance their anti-inflammatory properties. He serves as a permanent member of the NIH/NINDS BINP study section and on the CIRM Grants Working Group review panel.
Tuesday, September 15, 2020
8:00 PM – 9:00 PM